ArticleCureus2025
Carotid Intima-Media Thickness in Chronic Kidney Disease: Evidence of Early Vascular Injury in a Tertiary Care Cohort in Northeast India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond biochemistry: multiparametric ultrasound parameters and their molecular correlates in cardio-renal-metabolic syndrome.Acta biochimica Polonica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Chronic kidney disease (CKD) is associated with a markedly increased cardiovascular risk that is often underestimated by traditional risk prediction models. Carotid intima-media thickness (CIMT) is a noninvasive marker of subclinical vascular injury, but data from Northeast India remain limited. Methods We conducted a cross-sectional study of 160 adults with CKD stages I to V attending a tertiary care center in Northeast India. Patients with a prior history of myocardial infarction, stroke, or vascular revascularization were excluded. CIMT was measured bilaterally using high-resolution B-mode ultrasonography, with three measurements obtained on each side and averaged to derive a participant-level mean. Abnormal CIMT was defined a priori as greater than 0.9 mm. Associations between CIMT and clinical variables were evaluated using multivariable linear regression adjusted for age, sex, CKD stage, hemodialysis status, hypertension, diabetes mellitus, and smoking. Results The mean age of participants was 40.3 ± 11.7 years, and 71.3% were male. Stage V CKD was the most common stage, accounting for 40.6% of patients. The overall mean CIMT was 1.04 ± 0.26 mm, and abnormal values were present in 122 of 160 participants (76.3%). Mean CIMT exceeded 0.9 mm by stage IIIa CKD. Patients receiving hemodialysis had significantly higher CIMT compared with those not on hemodialysis. In adjusted analyses, more advanced CKD stage, hemodialysis status, hypertension, and older age were independently associated with higher CIMT, while sex, diabetes mellitus, and smoking were not. Conclusions In this relatively young CKD cohort, a high burden of subclinical vascular injury was observed, with clinically significant carotid wall thickening detectable by stage IIIa. These findings support the use of CIMT as a practical adjunct for cardiovascular risk assessment in patients with CKD in resource-constrained settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.